MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Synthetic Biologics Company Profile (NYSE:SYN)

Consensus Ratings for Synthetic Biologics (NYSE:SYN) (?)
Ratings Breakdown: 1 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $3.50 (28.21% upside)

Analysts' Ratings History for Synthetic Biologics (NYSE:SYN)
Show:
DateFirmActionRatingPrice TargetActions
6/4/2015HC WainrightSet Price TargetBuy$4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2015William BlairInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/16/2015Maxim GroupDowngradeBuy -> Hold$3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/2/2015Maxim GroupLower Price TargetBuy$6.00 -> $3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/19/2014Maxim GroupBoost Price TargetBuy$3.00 -> $6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/17/2013Noble FinancialInitiated CoverageBuy$3.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/30/2013Maxim GroupInitiated CoverageBuy$3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/7/2013 forward)